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Abstract 
Stretch activation is described as a delayed increase in force after an imposed 
stretch.  This process is essential in the flight muscles of many insects and is also 
observed, to some degree, in mammalian striated muscles.  The mechanistic basis for 
stretch activation remains uncertain, although it appears to involve cooperative activation 
of the thin filaments (12, 80).  The purpose of this study was to address myofibrillar 
regulatory mechanisms of stretch activation in mammalian striated muscle.  For these 
studies, permeabilized rat slow-twitch and fast-twitch skeletal muscle fibers were 
mounted between a force transducer and motor, and a slack-re-stretch maneuver was 
performed over a range of Ca2+ activation levels.  Following slack-re-stretch there was a 
stretch activation process that often resulted in a transient force overshoot (PTO), which 
was quantified relative to steady-state isometric force.  PTO was highly dependent upon 
Ca2+ activation level, and the relative magnitude of PTO was greater in slow-twitch fibers 
than fast-twitch fibers.  In both slow-twitch and fast-twitch fibers, force redevelopment 
involved a fast, Ca2+ activation dependent process (k1) and a slower, less activation 
dependent process (k2).  Interestingly, the two processes converged at low levels of Ca
2+ 
activation in both fiber types.  PTO also contained a relaxation phase, which progressively 
slowed as Ca2+ activation levels increased and was more Ca2+ activation dependent in 
slow-twitch fibers.  These results suggest that stretch activation may not be solely 
regulated by the extent of apparent cooperative activation of force due to a higher relative 
level of stretch activation in the less cooperative slow-twitch skeletal muscle fiber.  Next, 
we investigated an additional potential molecular mechanism by regulating stretch 
activation in mammalian striated muscle.  Along these lines, our lab has previously 
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observed that PKA-induced phosphorylation of cMyBP-C and cTnI elicited a significant 
increase in transient force overshoot following slack-re-stretch maneuver in 
permeabilized cardiac myocytes (29).  Interestingly, in slow-twitch skeletal muscle fibers 
MyBP-C but not ssTnI is phosphorylated by PKA (28).  We, thus, took advantage of this 
variation in substrates phosphorylated by PKA to investigate the effects of PKA-induced 
phosphorylation of MyBP-C on stretch activation in slow-twitch skeletal muscle fibers.  
Following PKA treatment of skinned slow-twitch skeletal muscle fibers, the magnitude of 
PTO more than doubled, but this only occurred at low levels of Ca
2+ activation (i.e., ~25% 
maximal Ca2+ activated force).  Also, force redevelopment rates were significantly 
increased over the entire range of Ca2+ activation levels following PKA treatment.  In a 
similar manner, force decay rates showed a tendency of being faster following PKA 
treatment, however, were only statistically significantly faster at 50% Ca2+ activation.  
Overall, these results are consistent with a model whereby stretch transiently increases 
the number of cross-bridges made available for force generation and PKA 
phosphorylation of MyBP-C enhances these stretch activation processes. 
1 
Introduction 
The fundamental, functional unit of mammalian striated muscle is the sarcomere, 
which encompasses three main filamentous components; thick filaments, thin filaments, 
and the titin filament.  The thick filament consists predominantly of myosin molecules 
and also contains MyBP-C molecules arranged in periodic intervals in each half of thick 
filaments.  The thin filament is comprised primarily of three molecules: actin, troponin, 
and tropomyosin.  The third filament mainly consists of the large protein titin, which 
extends from the Z-line to the M-line of the sarcomere. 
Thick Filament 
Myosin 
The major component of the thick filament is myosin.  The myosin molecule is 
comprised of two globular motors attached to a coiled coil α-helical tail (13).  The tail is 
156 nm long which includes a 43 nm hinged portion (S2 region) that connects to the S1 
(head and neck) region of the molecule (65).  Each myosin molecule contains two heavy 
chains and four light chains (55).  The heavy chains embody the tail, neck and head 
regions and play the primary role in myosin’s interaction with actin that underlies 
contraction.  The myosin light chains appear to have more of a structural and regulatory 
role in striated muscle.  In fact, one class of light chains are referred to as regulatory light 
chains (MLC2) (37, 73), whose phosphorylation has been shown to modulate Ca2+ 
sensitivity of force and rate of force development (50) and its level of phosphorylation 
has been found to be depressed in heart failure (71, 90).  The myosin head is known to 
interact cyclically with both ATP and actin.  ATP hydrolysis is thought to provide the 
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energy that yields the conformational changes in myosin that generate force and filament 
sliding in the sarcomere (13).  The acto-myosin/ATPase cycle during muscle contraction 
is as follows:  
 ATP binds myosin, myosin rapidly dissociates from actin 
 ATP hydrolysis becomes ADP + Pi and myosin forms weakly bound 
cross-bridges with actin 
 Release of Pi elicits a strongly bound force generating cross-bridge 
 ADP dissociates from myosin 
 Cycle repeats 
 
Figure 1. Myosin Cross-bridge Cycle. The cross-bridge cycle is thought to occur in four states. 
(A) ATP bound to myosin. Cross-bridge unbound.  (B) ATP hydrolysis (ADP + P) leads to 
formation of weakly bound cross-bridge.  (C) Inorganic phosphate is release from myosin head 
generating a strongly bound non-force generating cross-bridge.  (D) Release of ADP causes 
strongly bound cross-bridges to generate force. Adaption of model from (13).  
During isometric contraction, each cross-bridge produces between 2-10 pN of 
force (13).  There is still debate as to if each ATP leads to one cross-bridge cycle (tightly 
coupled lever arm hypothesis) or if the one ATP can elicit multiple myosin head cycles in 
a ratchet-like manner (loosely coupled hypothesis) (23).   
(A) (D) (C) (B) 
(Unbound) (Strongly bound 
force generating) 
(Strongly bound 
force generating) 
(Weakly Bound) 
    Cross-bridge State      
3 
 
Myosin Binding Protein-C 
Myosin binding protein-C was first discovered in 1971 as a protein with a 
molecular weight that was too small to be a myosin heavy chain, but too big to be a light 
chain (77).  It was thought to be a contaminant of myosin purification preparations and 
labeled C-protein based on its migration pattern relative to other bands (i.e., third band 
from the top).  C-protein was later found to interact with myosin and re-named myosin 
binding protein-C (MyBP-C).  MyBP-C is a 140-150 kDa elongated, flexible polypeptide 
that is ~40nm long and ~3 nm wide (31).  MyBP-C occurs in sets of 2-3 molecules which 
are located in the middle third of each half sarcomere in ~7-11 transverse stripes 
separated by ~43 nm (6).  A portion of MyBP-C structure appears lie in parallel to the 
thick filament while the remainder of the molecule extends radially towards the thin 
filaments (31).  MyBP-C is known to have a strong binding affinity for the S2 and S1 
regions on myosin (1, 54, 76) and can bind  actin with micromolar affinity (53), which 
provides a means to alter its interfilament binding and play a modulatory role regulation 
of myofibrillar contraction.  In support of this, ablation of MyBP-C has been shown to 
speed rates of both force development (38, 79) and sarcomere shortening (34, 38).  
MyBP-C contains 3 serine residues that are the primary PKA phosphorylation sites 
(mouse: Ser-273, -282 and -302; human Ser-275, -284, and 304 (2, 5).  The exact role of 
MyBP-C  phosphorylation  remains uncertain but has been shown to increase the length 
dependence of contraction (40), speed rates of force development (82), speed relaxation 
rates (87) and recently increase stretch activation in skinned cardiac myocardial 
preparations (45).   
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Thin Filament  
Actin 
 Actin is the major component of the thin filament.  Actin is comprised of two 
helical F-actin strands coiled together in an alpha helix with a pitch of ~73 nm (60); the 
pitch of a helix is defined as the distance of one complete helical rotation.  Each F-actin 
strand is comprised of individual globular actin (g-actin) subunits polymerized together 
in a series.  Each g-actin monomer is roughly 5.46 nm in diameter (75) and consists of 
four subdomains.  Subdomains 1 & 2 project into the periphery for interactions with 
various proteins while 3 & 4 form the core of the actin filament subdomains (8, 52, 70).  
Each structural unit of the thin filament, known as the thin filament regulatory unit, 
consists of 7 actin monomers in a series (55).  Actin is anchored to the Z-line of the 
sarcomere by a barbed capping protein CapZ (63), which is needed for effective force 
transmission and relative filament sliding (35).  Sarcomeric actin’s main functional 
interaction involves its cyclical interaction with myosin heads, which is thought to 
provide the basis for striated muscle contraction.  However, in the intact myofibrillar 
lattice, actin is not always readily available for interaction with myosin heads.  In the 
relaxed state, myosin binding sites on actin are allosterically inhibited by regulatory 
molecules on the thin filament (39).   
Troponin Complex 
 The regulatory molecules include the cable-like tropomyosin molecule and 
troponin complexes, which together act as Ca2+ sensitive regulators of contraction.  The 
troponin (Tn) complex is comprised of three molecules, troponin C (TnC) which binds 
Ca2+, troponin I (TnI) which is the inhibitory molecule, and troponin T (TnT) which 
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binds to tropomyosin (Tm).  There is one troponin structure per thin filament regulatory 
unit (23).  TnC is a 17 kDa dumbbell shaped molecule that contains EF hands (helix-
loop-helix structure) which are Ca2+ binding sites (32).  Troponin I, an inhibitory 
molecule (30), ranges in size from 27-31 kDa depending on its isoform (44).  The cardiac 
isoform of TnI contains a 30 amino acid N-terminal extension which contains several 
phosphorylation sites (27).  The third subunit of troponin is TnT which is a ~18.5 nm 
molecule that has been described as the “glue” of the regulatory complex together (86).  
The COOH-terminus of TnT is located in the globular region on Tn, while the NH2-
terminus is extended along the Tm (86).  PKA-induced phosphorylation of cTnI at the 
serine 23/24 residues elicits faster relaxation rates due in part to an allosteric effect that 
reduces the Ca2+ binding affinity of cTnC, eliciting more rapid Ca2+ dissociation from 
cTnC and removal from the cytosol (67).  The serine 23/24 residues are absent in the 
skeletal isoforms of TnI.  TnT is thought to contribute to cooperative activation of force 
development via its interaction and influence on Tm (22).   
Tropomyosin  
 The final major component of the thin filament is Tm.  Tropomyosin is a ~ 42 nm 
long dimer in a coiled coil alpha helix (23).  There is one Tm molecule per actin filament 
regulatory unit (7 G-actin) (23), as well as one Tm filament per F-actin strand, yielding 
two Tm filaments per thin filament.  Tropomyosin molecules arrange in a head-to-tail 
configuration with a periodicity of 38.5 nm along actin (23).  When first discovered, Tm 
was thought to be a precursor for myosin (3); however, it is now thought that 
tropomyosin’s main function is to regulate contraction via inhibition of the actin myosin 
interaction (39).  In relaxed muscle, tropomyosin lies in the groove of the subdomain 1 of 
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actin monomers on each of the actin filaments; this is thought to sterically inhibit myosin 
binding to actin subdomain (23).  Phosphorylation of Tm serine 283 causes a 
straightening and stiffening of the head-to-tail configuration of Tm (41), which is thought 
to elicit greater thin filament activation via increased level of cooperative activation.  
Further evidence of the head-to-tail overlap’s contribution was seen as a decrease in 
cooperativity following removal of overlap (56).  There are three different states that 
tropomyosin can exist in, blocked, closed, and open.  The transition between these states 
is driven by Ca2+ and the presence of strongly bound cross-bridges (SBXB).  The 
tropomyosin transitions from the blocked state to the closed state following the 
introduction of Ca2+.  Ca2+ enters the sarcomere, binds to TnC causing conformation 
changes in troponin which leads to tropomyosin shifting its position into the closed state.  
Once in the closed state, myosin heads can then strongly bind to actin which transition 
the tropomyosin to its open state which leads to further contraction.  
Titin Filament 
 Titin is comprised of extensible and non-extensible regions.  The extensible 
region of titin is comprised of tandem immunoglobulin (Ig) repeats and a PEVK region 
(rich in proline, glutamate, valine, and lysine) (25).  There is evidence that the titin 
molecule binds to both the thin and thick filaments as it spans the entire length of the half 
sarcomere (z-line to m-line) (24, 25).  Since titin binds to several molecules within the 
sarcomere, it provides a scaffolding for proper interfilament spacing (89).  When first 
discovered titin was thought to be a collection of polypeptides that formed into a protein 
complex (92); however, titin is now known to be a protein derived from a single gene that 
is ~3800 kDa, spans the entire half-sarcomere, and is thought to play a major role in 
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determining passive force in striated muscle (25).  In mammalian heart there are two 
different isoforms of titin:  N2B (a shorter isoform with high passive force) and N2BA (a 
longer isoform with low passive force) (25).  PKA-mediated phosphorylation of titin has 
been shown to reduce passive force while PKC mediated phosphorylation tends to stiffen 
titin and increase passive force implicating an important modulatory role of titin in both 
passive extension and recoil of the sarcomere (18, 25).   
Ca2+ Regulation of Contraction  
As described above muscle contraction has been canonically thought to be 
regulated by Ca2+ activation of the thin filament (Fig. 2).  The process of Ca2+ regulation 
of skeletal muscle contraction is summarized as follows (23, 55):  
 Action potential causes release of ACh from the motor nerve 
 ACh binding to motor end plates elicits depolarization 
 Action potentials propagate along sarcolemma 
 Voltage gated sarcolemma channels physically interact to open SR Ca2+ 
channels 
 Ca2+ released from the sarcoplasmic reticulum 
 Ca2+  binds Troponin C 
 Change in conformation of TnC, TnI, and TnT 
 TnT moves Tropomyosin which unveils the myosin binding site on actin 
monomers 
 Myosin binds actin (cross-bridge) 
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o Cross-bridge power stroke driven by free energy of ATP (see 
ATP/myosin cross-bridge cycle step by step process) 
 Ca2+ detachment from TnC 
 Ca2+ reuptake by the SR 
 Detachment of remaining cross-bridges 
 Muscle Relaxation 
 
Figure 2.  Thin Filament Regulation of Contraction.  Half sarcomere model of Ca2+ regulation of 
contraction.  Ca2+ (tan) binds to TnC (orange) which cause a change in confirmation of Tnc and 
TnI (pink).  Tm (blue) undergoes an azimuthal shift exposing the active binding sites on actin 
(gray), which allows myosin heads (green) to bind to actin and generate force. 
Dual-Filament Regulation of Contraction  
 A novel model of muscle contraction involves dual-filament regulation (42).  
According to this model the thin filament is still primarily regulated by Ca2+, but in 
addition the thick filaments can be modulated at least in part by strain of stress imparted 
on them.  The thick filament is modeled to exist in three transition states:  
 In a super-relaxed state (zero activating Ca2+ and no external load), both the 
thin and thick filaments are in the OFF state (Fig. 3a). 
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 After the filaments are exposed to Ca2+ and the thin filaments are activated, 
there is population of cross-bridges that are modeled to be constitutively 
primed for activation.  These cross-bridges exclusively are thought to engage 
the thin filament when the load on the muscle is very low such as when 
sarcomeres shorten at very high (near maximal) rates (Fig. 3b).  In this case, it 
is thought that less than 5% of the myosin motors are necessary to drive 
shortening (59), which is the population of cross-bridges that are modeled to 
be constitutively ON or primed (Fig. 3, green ellipses). 
 The third state of the thick filament arises when an external load (either 
elicited by high stress or strain) is applied to the muscle.  In this case the 
constitutively ON cross-bridges generate stress in the thick filament, which, in 
turn, releases a population of cross-bridges motors from the OFF state (Fig. 
3c).  It is only in this state that full isometric force can be produced. 
10 
 
 
Figure 3.  Dual Filament Regulation of Muscle Contraction.  A. Resting muscle. Thin and thick 
filament both in OFF state (red).  B. Muscle under low load Ca2+ activation.  Thin filament in ON 
state (green) while thick filament remains in OFF (red) state, except constitutively ON myosin 
heads (green ellipses).  C. Muscle under high load Ca2+ activation. Thin and thick filament both 
in ON state (green). Adaption of model from (42). 
Insect Flight Muscle 
Insect flight muscles (IFM) are divided into two major groups, synchronous and 
asynchronous muscles.  Synchronous flight muscles have a 1:1 ratio of neural signals to 
contractions.  Each contraction of synchronous flight muscle is initiated by intracellular 
Ca2+ release and terminated by SR Ca2+ reuptake, which is similar to mammalian striated 
muscle.  However, asynchronous flight muscles are divergent.  The have roughly a 1:10-
40 ratio of neural signal inputs to muscle contractions (46).  Asynchronous IFM perform 
oscillatory wing beats at such a frequency (up to ~500 Hz (46, 93)) that sarcoplasmic 
A 
B 
C 
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reticulum (SR) Ca2+ release and reuptake would not be able to keep up, and the addition 
of more SR to the muscles would be very metabolically costly (36).  Therefore, 
asynchronous IFM has evolved an additional mode of regulation beyond Ca2+ 
oscillations, quantal summation of force, and temporal summation of forces; this 
mechanism of regulation is known as stretch activation. 
Stretch activation in IFM was first observed in the late 1940s when JWS Pringle 
observed a delayed increase in force after just a slight muscle lengthening (62).  Stretch 
activation since has been vastly accepted as a regulator of asynchronous IFM contraction 
(10, 36, 43, 58, 61).  In order for stretch activation to be optimally utilized in a functional 
manner by these insects, there must be two antagonistic muscle groups.  These muscles 
groups will work synergistically with each other to elicit stretch activation, i.e. the 
contraction of one muscle group stretches and thereby activates the other antagonistic 
muscle group and vice versa (36, 43, 61).  The regulation of contraction via stretch 
activation is thought to occur as follows (10):  
 Action potentials originating from neural inputs propagate along the 
sarcolemma 
 Ca2+ enters the muscle and is maintained at a low level 
 Ca2+ activates the thin filament on the agonist muscle group 
 Contraction of the agonist muscle group stretches antagonistic muscle 
group which provide the trigger for its thin filament activation and 
subsequent contraction while the agonist muscle group deactivates and 
relaxes  
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 The contraction and shortening of the antagonist muscle group then 
stretches the relaxed agonist muscle group (mechanical feedback loop) 
 Elicits 10-40 wing beats per neural impulse 
 
IFMs have evolved their sarcomere in several different ways to accommodate this 
additional regulation of contraction.  In IFM, the periodicity of troponin on the thin 
filament and myosin cross-bridges is 38.7 nm (58), which favors interaction because the 
preferred myosin binding site on actin is midway between each troponin complex (88).  
Insects also have two different isoforms of TnI in their muscles, a larger isoform (53kDa) 
in IFM, while having a smaller isoform (22kDa) in the insect leg muscles (10).  The 
larger, IFM isoform of TnI is referred to as heavy troponin (TnH) (9).  The N-terminus of 
TnH is similar to TnI; however, the C-terminus of TnH is rich in proline, alanine, and 
glutamic acid similar to Tm. TnH is at all troponin sites on the thin filament and is now 
known to be the location of troponin bridges.  Troponin bridges extend from troponin on 
the thin filament to the thick filament (58).  These bridges occur when myosin heads bind 
to troponin in “non-target” areas of the thin filament, which causes and inhibition of 
contraction.  However, following stretch of the muscle, these bridges push (or pull) the 
Tn-Tm complex on actin from a closed position to open (58).  IFM also has two isoforms 
of TnC (64).  One of the isoforms, F2 TnC, produces a Ca2+ graded isometric contraction 
similar to that of mammalian striated muscle.  However, the other isoform, F1 TnC, 
which lacks the NH2-teminal Ca
2+ binding site, is capable of activating the muscle 
through stretch via interactions with the Tn complex (64).  Both isoforms exist in all 
myofibrils of the insects, but the ratio of F1:F2 in IFM is 10:1.  
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Recent findings have led to the theory that troponin-myosin bridges are the 
regulators of stretch activation in IFM (10, 58).  A proposed molecular theory of 
regulation by stretch activation is as follows:  
 In a relaxed, Ca2+ free state Tm is covering the binding sites on actin, and 
TnH is extended across the sarcomere to form a troponin bridge with myosin 
(Fig. 4a) 
 Upon exposure to Ca2+ (which binds F1 TnC), thin filament is in a partially 
open state. 
 Once sarcomere is stretched, TnH is pulled/pushed away from actin which 
subsequently moves tropomyosin.  This causes actin to be in the active state 
which allows myosin to bind to the desired binding site and subsequent force 
generation. 
 Upon shortening the thin and thick filaments make the transition to the relaxed 
or OFF state. 
14 
 
 
 Figure 4.  Model of Stretch Activation in IFM.  A. Resting muscle, Tm is blocking target sites on 
actin.  Troponin bridges are flanked by target sites.  B. Ca2+ binds to TnC, transitioning the thin 
filament into the partially open state.  C. Upon stretch, TnH is pulled away from actin, Tm moves 
to the open state and crossbridges bind to exposed target sites.  D. Muscle contracts as the strain 
is released.  The sarcomere will then return to state B. Adaption of model from (58). 
 
 
* * A.  
Relaxed 
B.  
Ca
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 Activated 
C. 
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D. 
Contraction 
* * 
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Stretch activation in IFM has been found to increase active force greater than 2-
fold over isometric force in a length independent manner (93).  It is postulated that insect 
are able to vary the amount of stretch activation being utilized in order to accommodate 
this broad spectrum of both power per and frequency of wing beat (43, 93).   
Stretch Activation in Mammalian Striated Muscle 
 While stretch has long been known to regulate contraction in IFM, it is less 
accepted  as a regulator of contraction in striated muscle, even though there has been a 
considerable number of studies in support of stretch activation in striated muscle dating 
back to 1970 (68).  Rüegg and associates found that a quick 0.2 to 0.5% muscle length 
stretch of rabbit psoas muscle fibers elicited a transient delayed increases in force.  It has 
since been found that both mammalian cardiac and skeletal muscle has the capacity to 
utilize stretch activation.  In addition, PKA treatment of cardiac and skeletal have been 
known to modulate force redevelopment and stretch activation (29, 83, 87). 
Cardiac Muscle 
 Stretch activation has been studied in mammalian cardiac muscle since 1971 (78).  
Mammalian cardiac muscle utilizes repetitive oscillatory contractions to function in a 
similar manner as IFM.  Due to this, it can be inferred that mammalian cardiac muscle 
may have similar regulatory mechanisms of contractions (91).  However, the underlying 
mechanism of stretch activation in the heart remains uncertain.  There is evidence of 
stretch activation during systolic contraction, in which early contraction of the ventricular 
endocardium stretches the epicardium which is later activated.  Studies have shown that 
the ventricle utilizes a torsional contraction in the counter-clockwise direction (viewed 
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from apex) (16).  The endocardium is activated first and contracts in a clockwise 
direction.  The epicardium is activated shortly after and over powers the endocardium in 
order for the ventricle to contract in a counter-clockwise manner (16).  It was postulated 
that the more forceful epicardial contraction may stretch-activate the endocardium, 
allowing for a coordinated twisting of the ventricle for optimal wringing and ejection of 
blood.    A potential mechanism of stretch activation during mammalian cardiac cycle:   
 Ventricle fill during diastole. 
 Upon Ca2+ activation, the ventricular endocardium begins to contract in an inner 
right-handed helix, while the epicardial subsequently activates in an outer left-
handed helix.   
 The epicardial tends to overpower the endocardium, thought, in part, to be due to 
elevated regulatory myosin light chain phosphorylation (15), which stretches the 
endocardium during activation.  This is theorized to stretch activate the 
endocardium to elevate its angular velocity which contributes to optimal wringing 
and “bottom-up” ejection of blood.   
 
There is considerable evidence for stretch activation in cardiac myofibrillar 
preparations (16, 29, 78, 80).  Unlike the IFM, there is a stretch magnitude dependence of 
force in mammalian cardiac muscle.  For instance, mammalian myocardium exhibited 
increases in force with increasing sizes of length steps (80) but the amplitude of stretch-
activated force in cardiac muscle was much smaller than IFM.  Mammalian myocardum 
has a multiphasic force response to stretch (80).  Following a stretch of permeabilized 
cardiac myocyte preparations there is a multi-phasic mechanical response.  First, there is 
an initial spike in force that coincides with stretch (phase 1), thought to be due to a strain 
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on the attached cross-bridges, followed by a quick decay of force (phase 2), thought to be 
the detachment of stained cross-bridges from thin filament, and finally a slow, delayed 
increase in force (phase 3) which is thought to be a result of stretch activation. 
The mechanism of stretch activation in mammalian cardiac muscle remains uncertain 
although it appears to involve cooperative activation (79).  Cooperative activation is a 
mechanism of force generation by which the binding of one myosin head increases the 
likelihood of downstream activation of the thin filament.  This allows greater activation 
via an increase in the numbers of strongly bound cross-bridges.  Interestingly, stretch 
activation has been found to increase in mammalian cardiac tissue following PKA 
treatment (29, 83).  PKA phosphorylates cMyBP-C and cTnI (29), which causes an 
increase in stretch-activated force in mammalian cardiac tissue.  
Skeletal Muscle 
 Skeletal muscle tends to operate in a physiologically different manner than 
cardiac muscle whereby voluntary skeletal muscle contractions can be followed by very 
long intervals of relaxation (secs to hrs) whereas cardiac muscle functions as pump that 
requires constant involuntary contraction/relaxation cycles on a second-by-second basis.  
However, skeletal muscle can function in repetitive oscillatory manner if one considers 
the contraction/relaxation cycle of a muscle during repetitive activity.  When a muscle 
group and its antagonist muscle group is taken into consideration, a scenario for potential 
stretch activation arises; for example, during running, contraction of the hamstrings may 
stretch the quadriceps as they are beginning to be activated for the next cycle of knee 
extension.  If indeed skeletal muscle has the capacity to utilize stretch activation, it is 
possible that it would occur via the following mechanism in leg muscles: 
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 Neural signals activate quadriceps muscle group 
 Contraction of quadriceps, which stretches hamstrings just when the hamstrings 
are beginning to be activated  
 Stretching yield additional activation of the hamstrings 
 Hamstrings contract and shorten, which leads to stretch activation of the 
quadriceps muscle group 
 
Stretch activation was first evaluated in mammalian skeletal muscle in 1970 on 
frog semitendinosus and rabbit psoas muscle groups (68).  Small stretches of the skeletal 
muscle elicited a similar delayed increase in force as IFMs.  However, the increase in 
force in skeletal muscle following stretch was substantially smaller than the force 
increase of IFMs.  The delayed increase in force was also transient in skeletal muscle 
unlike IFM.  Stretch activation was theorized to occur in skeletal muscle, which  is 
capable of spontaneous oscillatory contractions (SPOCs) (84), because stretch activation 
was known to occur during IFM oscillatory contractions.  Stretch activation has been 
found to vary in skeletal muscle based on myosin heavy chain isoforms (20).  The various 
fiber types all have the delayed increase in force following an imposed stretch; however, 
the kinetics of the force redevelopment were very susceptible to MHC isoforms (20). 
One theorized mechanism of stretch activation in skeletal muscle encompasses the 
SPOCs.  SPOCs are theorized to occur via an autonomous interaction between the thick 
and thin filament that hydrolyzes ATP at low Ca2+ levels.  SPOCs coupled with 
decreased lattice spacing upon stretch has been proposed as a possible mechanism of the 
delayed increase in force (74).  Another theorized mechanism of stretch activation in 
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skeletal muscle involves cooperative activation (12).  Slow-twitch skeletal muscle fibers, 
during steady-state, submaximal Ca2+ activations, exhibited a transient force overshoot 
following a slack-re-stretch maneuver.  To study whether recruitment of additional cross-
bridges was involved in the transient force overshoot, Campbell (12) implemented small 
length perturbations on the skinned slow-twitch skeletal muscle fibers during force 
redevelopment to quantify the stiffness of the fiber, which was used an index in the 
number of force-generating cross-bridges (17).  During force redevelopment, the stiffness 
of the muscle fiber preparation was highly correlated to the relative force redeveloped 
implicating that additional cross-bridges perhaps by cooperative recruitment may cause 
the observed transient overshoot of force (12).  If indeed, cooperative recruitment of 
cross-bridges is the mechanism for transient force overshoot, it stands to reason that fast-
twitch skeletal muscle fibers would have greater magnitude of transient force overshoot 
compared to slow-twitch skeletal muscle fibers since fast-twitch skeletal muscle is known 
to have a higher relative level of cooperativity compared to the slow-twitch fibers (21, 
47).  
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Figure 5. Tension-pCa Relationships in Muscle Types. Steepness of the tension-pCa curve was 
assesed at ~50% Ca2+-activated forces.  Fast-twitch fibers displayed a steeper tension-pCa curve 
than slow-twitch fibers, indicative of a higher cooperativity of Ca2+ activation in fast-twitch 
fibers.  Cardiac myocytes (○), fast-twitch skeletal muscle fibres (●), and slow-twitch skeletal 
muscle fibres (▼).  Taken from (47).  
Hypothesis 
If stretch activation is in fact due to cooperative activation of the thin filament, 
then the magnitude of the transient force overshoot will manifest greater in fast-twitch 
skeletal muscle fibers compared to slow-twitch fibers due to its higher relative level of 
cooperative activation, and in order to explore more into the molecular mechanism of 
stretch activation, we investigated the effects PKA-induced phosphorylation of MyBP-C 
on the transient force overshoot in slow-twitch skeletal muscle fibers. 
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Materials and Methods 
Experimental Animals 
All Procedures involving animals were performed in accordance with the Animal 
Care and Use Committee of the University of Missouri.  Male Sprague-Dawley rats (~2-4 
months), obtained from Harlan (Madison, WI), were housed in groups of two and 
provided food and water ad libitum.   
Solutions 
 Relaxing solutions for permeabilized skeletal muscle fibers contained: 1 mM 
DTT, 100 mM KCL, 10 mM Imidazole, 2.0 mM EGTA, 4.0 mM ATP, 1 mM (free, 5 
total) MgCl2.  Minimal Ca
2+ activating solution (pCa 9.0) for experimental protocol 
contained: 7.00 mM EGTA, 20 mM Imidazole, 5.42 mM MgCl2, 72.37 mM KCl, 
0.01633 mM CaCl2, 14.50 mM PCr, 4.7 mM ATP.  Maximal Ca
2+ activating solution 
(pCa 4.5) for experimental protocol contained: 7.00 mM EGTA, 20 mM Imidazole, 5.26 
mM MgCl2, 60.25 mM KCl, 7.01 mM CaCl2, 14.50 mM PCr, 4.81 mM ATP.  A range of 
Ca2+ concentrations for experiments was prepared by varying combinations of maximal 
and minimal Ca2+ solutions.  Pre-activating solution contained: 0.5 mM EGTA, 20 mM 
Imidazole, 5.42 mM MgCl2, 98.18 mM KCl, 0.016 mM CaCl2, 14.50 mM PCr, and 4.8 
mM ATP.  PKA solution prepared by diluting 1 mg DTT in 100 µL of bottle distilled 
water.  DTT solution was then added to PKA. 100 µL PKA was then diluted in 700 µL 
minimal Ca2+ solution.   
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Skeletal Muscle Fiber Preparation 
 Slow-twitch and fast-twitch skeletal muscle fibers were obtained from Sprague-
Dawley rats anaesthetized by inhalation of isoflurane (1mL: 4mL olive oil), and 
subsequently euthanized by excision of the heart.  Slow-twitch skeletal muscle fibers 
were obtained from the soleus muscle, while the fast-twitch skeletal muscle fibers were 
obtained from the psoas muscle.  The muscles were isolated and placed in relaxing 
solution.  Bundles of muscle fibers were separated and tied to capillary tubes.  They were 
stored in the freezer in 1:1 ratio of relaxing solution and glycerol for up to one month.  
On day of experiment single fibers were dissected from bundle by gentle pulling fibers 
from the end of bundle (48).   
Experimental Apparatus 
Prior to mechanical measurements the experimental apparatus was mounted on 
the stage of an inverted microscope (Model IX-70, Olympus Instrument Co., Japan), 
which was placed upon a pneumatic vibration isolation table.  Mechanical measurements 
were performed using a capacitance gauge force transducer (Model 403-sensitivity of 20 
mV/mg and resonant frequency of 600 Hz; Aurora Scientific, Inc., Aurora, ON, Canada).  
Length changes were presented to one end of the fiber via a DC torque motor (model 
308c, Aurora Scientific, Inc.) driven by voltage commands from a personal computer via 
a 12- or 16-bit D/A converter (AT-MIO-16E-1, National Instruments Corp., Austin, TX, 
USA) (47).  Fibers were attached between the force transducer and length motor by 
placing the ends of the fibers preparation into stainless steel troughs (25 gauge).  The 
ends of the fiber preparations were secured by overlaying a ~0.5 mm length of 3-0 
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monofilament suture (Ethicon, Inc.) onto each end of the fiber.  The suture secured the 
fiber into the troughs by two or three loops of 10-0 monofilament (Ethicon, Inc.) as 
shown in Fig.6.  The attachment procedure was performed under a stereomicroscope 
(+10x zoom).  The dimensions of the fiber preparations are summarized in Table 1.  
Force and length signals were digitized at 1 kHz and stored on a personal computer using 
Lab-View for Windows (National Instruments Corp.).  Simultaneous sarcomere length 
measurements of force and length were obtained via IonOptix SarcLen system (IonOptix, 
Milton, MA), which used a fast Fourier transform algorithm of the video image of the 
fiber.   
 
Figure 6. Skinned Fiber Apparatus. Skinned skeletal muscle fibers were mounted between a 
length motor and force transducer.  Experiment were performed in varying Ca2+ activating 
solutions. 
Slack-Re-stretch Protocol 
All mechanical measurements of skeletal muscle fibers were performed at 14 ± 1 
°C.  Following attachment, the relaxed skeletal muscle fiber preparation was adjusted to a 
sarcomere length of ~2.40 ± 0.1 nm by manual manipulation of the length micrometer on 
fiber mount.  The preparation was first transferred into pCa 4.5 solution for maximal 
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activation then subsequently transferred into a series of sub-maximal activating Ca2+ 
solutions, ending back in pCa 4.5 maximal activating solution.  At each pCa, steady-state 
tension was allowed to develop and the cell was rapidly slacked (~15% original muscle 
length) and re-stretched to original muscle length in order to elicit force redevelopment 
from zero tension (Fig. 7).  The fibers underwent ~3 slack-re-stretch maneuvers at each 
Ca2+ activation level.  Forces in sub-maximal activating solutions were expressed as a 
fraction of force obtained during maximal Ca2+ activation.  The maximal force value was 
calculated as an average of maximal force at the beginning and end of the experiment.  
To assess the effects PKA-induced phosphorylation of MyBP-C on the transient force 
overshoot, rate of force redevelopment, and transient force decay rate, the 
aforementioned slack-re-stretch protocol was performed before and after a 60 minute 
incubation with PKA (Sigma, 0.5 U/ml).  Ca2+ activating solutions were adjusted in order 
to elicit desired relative forces (25%, 50%, 75%, and maximal activation); the same sub-
maximal activing pCa solutions were used following PKA treatment in the respective 
fibers.  The first part of the protocol for the PKA experiments is the same as the 
comparative study of skinned slow-twitch muscle fiber preparations.  Therefore, the 
before PKA experimental values are similar to the slow-twitch muscle fiber experimental 
values. 
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Figure 7.  Slack-Re-Stretch Protocol.  Skinned fibers were submerged into Ca2+ activating 
solution.  Once isometric force was developed.  A ~15% slack was imposed on the muscle fibers, 
which was held for 20 msec, followed by re-stretch to original muscle length.  Force 
redevelopment was observed over 15-30 sec. 
Data Analysis 
 Often in the literature, force redevelopment traces are fit with a single exponential 
equation (12, 29, 81); however, during analysis it was found that often times the force 
redevelopment traces were better fit with a double exponential equation (Fig. 8).  Force 
was fit with the equation as follows:  
𝐹 = 𝐹𝑟 + 𝐴(1 − 𝑒
−𝑘1𝑥) + 𝐵(1 − 𝑒−𝑘2𝑥) 
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Where F is force during force redevelopment, and Fr is the residual force before 
redevelopment, and A is the force contributing to the first exponential phase, while k1 is 
the rate constant of force redevelopment of this first exponential phase, and B is the force 
contributing to the second exponential phase with a rate constant of k2. Force 
redevelopment was fit from Fr to maximal transient force elicited.   
 
Figure 8.  Force redevelopment trace and illustrative definition of annotations. 
Force redevelopment traces elicited various force characteristic values.  Once 
isolated, skeletal muscle fibers were submerged in Ca2+ activating solutions and allowed 
to rise to steady-state isometric force (PO).  Following slack-re-stretch maneuver, force 
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often redeveloped transiently to a maximal force (PTO+O).  Values for transient force 
overshoots were calculated by subtracting isometric force from the maximal redeveloped 
force(𝑃𝑇𝑂 = 𝑃𝑇𝑂+𝑂 − 𝑃𝑂).  Transient force overshoots were analyzed relative to 
isometric force (PTO/PO). 
Rates of transient force decay were calculated as follows:  
𝑡1 2⁄ = 𝑡𝑖𝑚𝑒𝑓𝑟𝑜𝑚 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑓𝑜𝑟𝑐𝑒 𝑡𝑜 𝑤ℎ𝑒𝑛 𝐹𝑜𝑟𝑐𝑒 =
0.95 ∗ (𝑃𝑂+𝑇𝑂 − 𝑃𝑂)
2
 
Statistical Analysis  
Slow-twitch skeletal muscle fibers were compared to fast-twitch skeletal muscle 
fibers via Two-way ANOVA.  Slow-twitch skeletal muscle fibers before verses after 
PKA treatment were compared via paired t-test.  P-value below 0.05 is considered 
significant. * denotes significant difference. 
Results 
Ca2+ Dependence of Transient Force Overshoot in Skeletal Muscle Fibers 
Stretch activation is described as a delay increase in force following an imposed 
stretch (61).  The underlying mechanism of stretch activation remains unknown although 
it appears to involve cooperative activation of the thin filament (12, 80).  Our first study 
was to test the theory that stretch activation is regulated by cooperative activation in 
mammalian striated muscle.  This was done by a comparative study of stretch activation 
in slow-twitch and fast-twitch fibers.  As previously stated, stretch activation was 
hypothesized to be greater in fast-twitch fibers due to their greater relative level of 
cooperative activation (47).  Skinned skeletal muscle fibers (summarized in Table 1) 
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were activated to elicit 25%, 50%, 75%, and 100% maximal Ca2+ activation and once 
steady-state force was reached, a slack-re-stretch maneuver was performed.  Force 
redevelopment after the slack-re-stretch maneuver was often associated with a transient 
overshoot of force (PTO) (Fig. 9).  Both fast-twitch and slow-twitch skinned skeletal 
muscle fibers exhibited a Ca2+ dependence of PTO.  Submaximal (50%) Ca
2+ activation 
elicited the greatest magnitude of PTO, while maximal activation elicited the smallest PTO. 
 
Figure 9.  Ca2+ dependence of force traces following slack-re-stretch maneuver.  Representative 
sarcomere length trace.  Representative absolute force traces following a slack-re-stretch 
maneuver from a slow-twitch (blue) and a fast-twitch (green) skeletal muscle fiber.  Force traces 
normalized to the steady-state force before the mechanical perturbation. 
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Table 1.  Skeletal Muscle Fiber Preparation Characteristics 
  Date 
Length 
(µm) 
Width 
(µm) 
Force (µN) 
at pCa 9.0 
Force (µN) 
at pCa4.5 
Tension 
(kN/m2) 
Slow-
twitch 
Fibers 
1/20/2016 1304 80 1.96 683 151 
3/3/2016 1000 87 0.98 668 125 
4/6/2016 904 61 1.47 339 129 
5/4/2016 1009 61 0.98 439 167 
6/14/2016 952 76 2.94 594 147 
Fast- 
twitch 
Fibers 
5/31/2016 1209 87 0.98 693 130 
6/2/2016 709 83 0.98 603 125 
6/7/2016 870 104 1.96 1204 157 
6/28/2016 1052 91 0.98 916 156 
Slow-
twitch 
Fibers 
Before 
PKA  
7/6/2016 970 91 5.39 730 125 
8/26/2016 1009 61 1.47 345 131 
11/22/2016 1004 83 4.9 625 130 
11/29/2016 1304 61 2.94 510 196 
Slow-
twitch 
Fibers 
After PKA  
7/6/2016 970 91 2.94 703 120 
8/26/2016 1009 61 0.98 342 130 
11/22/2016 1004 83 2.45 604 125 
11/29/2016 1304 61 1.47 500 192 
Sarcomere length was set at 2.40 ± 0.10 µm during Ca2+ activations. Solution 
temperature was set at 14.0 ± 1.0ºC. 
In order to compare the capacity for stretch activation between slow-twitch and 
fast-twitch skeletal muscle fiber types, transient overshoots of force (PTO) (i.e. the 
magnitude of force that transiently redeveloped above steady-state isometric force) were 
characterized from both fiber types.  Contrary to our hypothesis, force redevelopment in 
slow-twitch fibers elicited greater relative transient force overshoots than the more 
cooperative fast-twitch fibers over the spectrum of Ca2+ activation (see Table 2 for 
summary).  This indicates that slow-twitch skeletal muscle may have a greater capacity 
for stretch activation than fast-twitch skeletal muscle.  However, there was not a fiber-
type dependence of PTO at max Ca
2+ activation which is thought to arise from a lack of 
additional cross-bridges available for force generation following slack-re-stretch 
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maneuver.  Overall, these results suggest that stretch activation may not be solely 
regulated by the extent of apparent cooperative activation of force due to a higher relative 
level of stretch activation in the less cooperative slow-twitch skeletal muscle fiber.
 
Figure 10.  Transient force overshoot (PTO) in slow-twitch (blue) and fast-twitch (green) skeletal 
muscle fibers as a function of Ca2+ activation levels.  PTO was expressed as a fraction of steady-
state force (PO) before the slack-re-stretch maneuver.  Data points are mean ±SEM.  By two-way 
ANOVA, within slow-twitch and fast-twitch fiber groups, all PTO points were significantly 
different from each other except at ~25% versus ~75% forces.  * Slow twitch-fibers had greater 
relative transient force overshoot than fast-twitch fibers at all relative force values except for 
100% force. 
Force Redevelopment Rates 
Force development rates were characterized throughout the entire transient force 
overshoot process.  Force redevelopment traces have mostly been fit with a single 
exponential equation over a one second time frame (12, 29, 81).  We found that force 
redevelopment over several seconds that includes the transient force overshoot was well 
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fit with a double exponential equation, which implies two distinct molecular processes 
are involved in this prolonged force development phase of skeletal muscle myofilament.  
As seen in Fig. 11, force redevelopment over this time frame often involved a fast phase 
with the rate constant k1 followed by a slower phase with the rate constant k2.  Fast-twitch 
muscle fibers elicited faster rates of force redevelopment than slow-twitch muscle fibers 
over the entire range of Ca2+ activation.  Interestingly, in both fiber types, the two 
different processes of force redevelopment converge into one process at low Ca2+ (Fig. 
11) (all values summarized in Table 2).  The rate constant of the fast process (k1) was 
Ca2+ activation dependent, while the slower process (k2) was less Ca
2+ activation 
dependent.  This convergence of force redevelopment processes suggests that at low Ca2+ 
only one of the two molecular processes dominant in its contribution to force generation.   
 
Figure 11.  Force redevelopment rates.  Rate constants (s-1) from a double exponential (k1 and k2) 
fit across relative forces in slow-twitch (blue) and fast-twitch (green) fibers.  Values for k1 were 
highly dependent on Ca2+ activation levels, while k2 values were similar over the entire range of 
Ca2+ activation levels.  Values for k1 at ~75% and ~100% relative force were significantly 
different from all other values in both fiber types.  
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Force Decay Rates 
The rate of force decay was assessed in both slow-twitch and fast-twitch fibers. In 
this study, force decay rates quantified as the time to half decay of force (t1/2).  Similar to 
force redevelopment rates, fast-twitch skeletal muscle fibers had a faster decay rate of the 
transient force overshoot as shown by a smaller t1/2 (all values summarized in Table 2).  
Slow-twitch muscle fibers had a highly Ca2+ activation dependent force decay rate (t1/2 
was different at all Ca2+ activation levels).  However, the force decay rate in fast-twitch 
fibers was much less Ca2+ activation dependent (t1/2 at max Ca
2+ greater than other 
values). 
 
Figure 12. Force decay half-times (t1/2) of transient force overshoots.  t1/2 was Ca2+ activation 
dependent in a manner qualitatively similar to the k1 rate constant (in Figure 11).  In slow-twitch 
twitch fibers, the t1/2 at ~50% relative force was significantly different from all other values.  In 
fast-twitch fibers, the t1/2 at ~100% relative force was significantly greater than all other values. 
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Table 2. Characteristics of Force Redevelopment in Slow-twitch vs. Fast-twitch 
Muscle Fibers 
  
Rel. Force 
(%) 
PO/P4.5 (%) PTO/PO (%) k1 (s-1) k2 (s-1) t1/2 (sec) 
Slow-
twitch 
Fibers 
25 28.1 13.3 0.77 0.72 2.82 
50 49.5 24.6 2.07 0.91 5.51 
75 72.2 14.8 4.79 0.99 9.31 
100 99.8 1.2 6.08 0.97 10.54 
Fast-twitch 
Fibers 
25 23.7 5.77 1.83 1.83 1.11 
50 55.5 10.1 4.70 3.66 1.57 
75 74.5 5.88 14.19 4.71 2.16 
100 98.2 1.52 27.24 4.09 4.91 
 
PKA effects on stretch activation in slow-twitch skeletal muscle fibers 
Next we addressed the potential regulatory role that phosphorylation of 
myofilament proteins by PKA, which in particular has been shown to phosphorylate 
MyBP-C, plays in stretch activation in slow-twitch skeletal muscle fibers.  Our lab has 
previously observed that PKA-induced phosphorylation of cMyBP-C and cTnI elicited 
marked increases in transient force overshoots in permeabilized cardiac myocytes 
preparations (29).  To address the molecule specificity of this phenomenon we utilized 
skinned slow-twitch skeletal muscle fibers, which we have previously shown to be 
phosphorylated by PKA at MyBP-C sites but not TnI sites (28).  We, thus, took this as a 
model to study the effects of phosphorylating MyBP-C on stretch activation in 
mammalian skeletal muscle.  We hypothesized that PKA treatment would increase PTO 
over the entire range of Ca2+ activation due to phosphorylation of MyBP-C relieving its 
normal constraint on myosin heads. 
  The effect of PKA treatment on force redevelopment in slow-twitch skeletal 
muscle fibers was assessed by measuring the Ca2+ dependence of transient overshoot of 
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force before and after PKA incubation (Fig. 13).  (Fiber characteristics are summarized in 
Table 1)  
Figure 13.  Representative sarcomere length and force redevelopment traces during a slack-re-
stretch maneuver in skinned slow-twitch skeletal muscle fibers before and after PKA treatment.  
Representative sarcomere length traces before and after PKA treatment. Sarcomere length traces 
often elicited oscillations following PKA treatment.  Representative absolute force traces 
following a slack-re-stretch maneuver from a slow-twitch skeletal muscle fiber before (blue) and 
after (pink) treatment with PKA.  Representative relative force traces which were normalized to 
the steady state force before the mechanical perturbation.  
Once normalized to steady-state force isometric force, neither the magnitude of 
the transient force overshoot nor the force redevelopment rates appeared to be changed 
following PKA treatment  at maximal and 50%, 75% and maximal Ca2+  activation 
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levels.  However, at low Ca2+ activation levels (25% maximal Ca2+ activation) both the 
transient force overshoot and the force redevelopment rate was significantly increased 
following PKA treatment.   
PTO/PO values were similar before and after PKA treatment at the 50%, 75%, and 
100% Ca2+ activation levels.  However at low Ca2+ levels (25%), PTO more than doubled 
following PKA treatment (Fig. 14).  The relative transient force overshoot went from 
~19% to ~45% following PKA treatment (all values summarized in Table 3).  
 
Figure 14.  Transient force overshoot (PTO) in skinned slow-twitch skeletal muscle fiber 
preparations before (blue) and after (pink) treatment with PKA as a function of pCa (left) and 
relative force (right).  Relative transient force overshoot (PTO/PO) is shown as individual points 
(top) and mean ± bidirectional SEM (bottom).  Following PKA treatment, PTO/Po was 
significantly greater but only at low levels of Ca2+ activation.   
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Interestingly, force redevelopment rates were also increased after PKA treatment, 
which has been shown to phosphorylate MyBP-C.  However, unlike PTO, force 
redevelopment rates increased over the entire range of Ca2+ activation levels (26, 29, 45, 
57, 87).  The rates of force redevelopment were significantly increased for both the fast 
phase (k1) (Fig. 15) and the slower phase (k2) (Fig. 16) following PKA treatment.  As 
previously observed, the two phases of force redevelopment converged into one phase at 
low Ca2+ and this occurred both before and after PKA treatment. 
 
Figure 15.  Rates of the fast phase (k1) of force redevelopment before and after PKA.  Rate 
constants (s-1) are shown as both individual data points (top) and mean ± bidirectional SEM 
(bottom).  There was a statistically significant increase in k1 following PKA treatment at all pCa 
and relative force values.  * Denotes a statistically significant increase in PKA-induced rate 
constant vs before PKA treatment.  # Denotes significance not resolved due to low power of 
test. 
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Figure 16.  Rates of the slow phase (k2) of force redevelopment before and after PKA.  There was 
a statistically significant increase in k2 following PKA treatment at all pCa and relative force 
values.  Rate constants (s-1) are shown as individual data points (top) and mean ± bidirectional 
SEM (bottom).  *Denotes a statistically significant increase in PKA-induced rate constant vs 
before PKA treatment.  # Denotes significance not resolved due to low power of test.  
In a similar manner as force redevelopment rates, transient force decay rates had a 
tendency of being faster following PKA treatment.  However, t1/2 was only significantly 
smaller following PKA treatment at 50% activation (Fig. 17).  Also it should be noted 
that there was no t1/2 value at maximal Ca
2+ activation.  This was due to a lack of 
transient force overshoot at maximal Ca2+.  
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Figure 17.  Force decay half-times (t1/2) of transient force overshoots.  The t1/2 values are shown 
as a function of pCa (left) and relative force (right).  t1/2 following PKA treatment had the 
tendency of being lower (i.e, faster relaxation rates); however, it was only significantly decreased 
at 50% relative force.  The t1/2 at ~50% relative force was significantly different from all other 
values.  t1/2 values were not recorded at pCa 4.5 (maximum Ca2+ activation) due to the lack of a 
transient force overshoot.  # Denotes significance not resolved due to low power of test. 
Table 3. Characteristics of Force Redevelopment in Slow-twitch Muscle Fibers Before 
vs. After PKA Treatment 
  
Rel. Force 
(%) 
PO/P4.5 (%) PTO/PO (%) k1 (s-1) k2 (s-1) t1/2 (sec) 
Before 
PKA 
25 25.1 19.3 0.70 0.70 1.86 
50 46.7 26.8 1.50 0.93 3.35 
75 74.6 12.8 5.14 1.16 7.47 
100 100 0.923 7.33 1.28 -  
After PKA 
25 21.2 44.2 1.00 1.00 1.48 
50 49.7 27.3 1.74 1.20 2.94 
75 79.3 12.1 5.71 1.37 6.68 
100 99.8 1.52 8.01 1.51  - 
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Discussion  
Contraction of striated muscle has long been believed to be regulated through thin 
filament mechanisms (33).  Hitchcock et al. postulated that Tm can exist in two Ca2+ 
dependent states, a “blocked” state in which Tm sterically hinders the acto-myosin 
interaction or a “closed” state in which Ca2+ binding to Tn complex elicits a shift in the 
Tm position allowing acto-myosin interaction.  Tm is now believed to exist in three 
positions due to myosin binding being required for force generation (49).  The blocked 
and closed states of Tm remain the same in the two models, however, an additional 
“open” state exists (85).  The “open” state of Tm is reached upon binding of force 
generating cross-bridge.  A more recent model encompasses dual filament regulation of 
contraction has been postulated in recent years (42), by which the thin filament is Ca2+ 
activated, but the thick filament is stress activated.  This model was based in part due to 
the finding that myosin heads in a muscle under a low load remain in an OFF state.  This 
was concluded from x-ray diffractions correlating to the angle of the myosin heads and 
the periodicity of the thick filament.  Under low load state, the thin filament was 
activated, and the muscle could shorten at max velocity due to the constitutively ON 
cross-bridges.  These findings suggest that Ca2+ activation of the thin filament, which has 
been thought to be the canonical regulator of striated muscle contraction, may not be 
capable of solely regulating all muscle contraction. 
The main focus of this study was to investigate the myofibrillar regulatory 
mechanisms of stretch activation in mammalian striated muscle.  Slow-twitch skeletal 
muscle fibers elicited greater relative levels of stretch activation (PTO/PO) than the more 
cooperative fast-twitch skeletal muscle fibers.  This result suggests that stretch activation 
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may not be solely regulated by the extent of apparent cooperative activation of force 
since stretch activation did not manifest to a greater extent in the more cooperative fiber 
type.  Stretch activation may have not elicited as much of a transient force overshoot in 
fast-twitch fibers due to their fast force decay rates.  The faster rates of force decay would 
simply not allow enough time to overshoot force.  Another possible reason for this 
variation could be thin filament compliance.  According to some computational models, 
more compliant myofilaments increase recruitment of more force-generating cross-
bridges (11) due to additional realignment of myosin binding sites along the filament, 
which can lead to greater cross-bridge binding and more thin filament cooperative 
activation by shifting of Tm to open states (14). 
Force redevelopment and decay rates were 2-to-4 fold faster in skinned fast-
twitch skeletal muscle fibers compared to slow-twitch skeletal muscle fibers, which is 
consistent with previous studies (4, 51, 69).  The finding that force redevelopment was 
better fit with a double exponential equation suggests that force redevelopment is a 
biphasic response.  If in fact, force redevelopment is a biphasic response, then it may 
involve a more complex mechanism than can be explained by a simple two-state cross-
bridge cycling model as previously postulated (7, 94).  Interestingly, the two phases of 
force redevelopment converge at low levels of Ca2+ activation.  The rate constant of the 
faster process (k1) was more Ca
2+ activation dependent than rate constant of the slower 
process (k2).  Cooperative activation is thought to be a slow process indicative of k2.  k1 is 
likely a result of the cycling kinetics of the cross-bridges from detached to attached and 
force generating states and vice versa.  At higher levels of steady-state Ca2+ activation, 
there is a higher probability that considerable regions of both the thin and thick filaments 
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are activated such that the first order process of cross-bridge cycling limits the rate of 
force development.  However, at lower levels of Ca2+ activation more regions of both the 
thin and thick filament are in the off state and necessitate cooperative activation, which 
takes considerably more time in relation to cross-bridge cycling per se.  Force decay rates 
were faster and less Ca2+ activation dependent in fast-twitch skeletal muscle.  The lower 
Ca2+ dependence of transient force decay rates in fast-twitch skeletal muscle fibers may 
arise because fast-twitch skeletal muscle fibers have evolved a myofibrillar system that 
inactivates both its thin and thick filaments in a highly coordinated, cooperative switch-
like fashion to assist in its rapid relaxation and explosive contraction required for 
physiological function of that muscle type. 
Following PKA treatment, skinned slow-twitch skeletal muscle fibers elicited a 
doubling of PTO/PO (19% to 44%) at low Ca
2+ activation (25%).  This is consistent with 
the theory of dual filament regulation of contraction (42) (Fig. 3).  When the muscle is 
exposed to low stress (low Ca2+) the thin filament is activated, but the majority of the 
thick filament remains in the OFF state.  Thus at low levels of stress or force, there 
remains a large pool of cross-bridges available for force generation.  With regards to the 
role of MyBP-C and its phosphorylation by PKA in a relaxed/low stress state, the M 
domain of MyBP-C has a high affinity for the S2 region of the myosin which suppresses 
the myosin head increases its propensity to the OFF state (Fig. 18 left).  Based on 
biochemical studies quantifying cMyBP-C binding constants to myosin and actin, PKA-
induced phosphorylation of MyBP-C has been modeled to cause a shift in its M domain 
affinity from the myosin head to actin, which may increase the probability of myosin 
cross-bridges making the transition for the OFF to the ON state.  The myosin heads are 
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now primed for and more readily available for force generation (Fig. 18 right) by 
lowering the threshold of stress/strain required to activate the thick filament. This large 
pool of available cross-bridges may contribute to greater stretch activation.  PKA-induced 
phosphorylation of MyBP-C also elicited accelerated force redevelopment rates.  This 
may be due to an increase in the cross-bridge cycling kinetics or faster rates of either 
think or thick filament activation (82, 87). With increased faster force redevelopment 
rates likely due, at least in part, to increase in cross-bridge cycling kinetics (87), it might 
be expected that the force decay rates would be faster as well.  However, this was not 
observed at all Ca2+ activation levels, which may imply that MyBP-C phosphorylation 
may favor activation processes over inactivation processes.   
 
Figure 18.  MyBP-C regulation of Stretch Activation.  In a relaxed state, MyBP-C suppresses the 
myosin head in the OFF state (left).  Upon phosphorylation MyBP-C’s binding affinity is turned 
in favor of actin, which primes the myosin head to be available for force generation (right).   
Insect flight muscle and mammalian striated muscle differ structurally; however, 
they may regulate stretch activation via similar mechanisms.  Albeit IFM is theorized to 
regulate stretch activation via a thin filament mechanism, it is proposed in this thesis that 
stretch activation in mammalian striated muscle, at least in part, is regulated via a thick 
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filament mechanism.  It appears that there potentially is a molecular suppressor of 
contractile proteins in both muscle types, i.e. Tn-bridges in IFM and MyBP-C in 
mammalian striated muscle.  A proposed regulator of stretch activation in insect flight 
muscle is the Tn-bridges (10, 58).  In this model (Fig. 4), the Tn-bridges sterically hinder 
the thin filament to prevent full activation of the thin filament at low stress.  Under low 
stress, there are only weakly bound cross-bridges present.   Upon stretch, the troponin 
bridges are pulled which allows Tm to shift into the open state and the formation of 
strongly bound cross-bridges.  In a similar manner, MyBP-C may be a regulator of stretch 
activation in skeletal muscle.  As previously stated, MyBP-C has a high binding affinity 
for the S2 region of myosin and is also bound to actin.  In this model (Fig. 18), the high 
binding affinity of MyBP-C for myosin could sterically hinder myosin heads from 
interacting with actin and undergoing force-generating transitions.  However, upon 
MyBP-C phosphorylation, its inhibitory affect is alleviated, which may elicit greater 
degrees of stretch activation.  While these molecules and their primary filament of 
interaction differ between IFM and mammalian striated muscle, in essence, they may 
have similar roles in regulating stretch activation.  Although the phosphorylation of 
MyBP-C appears to play a role in the regulation of stretch activation, it remains possible 
that PKA phosphorylation of other myofibrillar proteins may contribute to the observed 
increase in the transient tension overshoot.  For example, titin is a known substrate for 
PKA and its PKA-mediated phosphorylation has been shown to cause increase titin 
extensibility and reduce passive force (25).  However, it seems counter intuitive that a 
more compliant titin molecule would in fact augment stretch activation.  In fact, previous 
(unpublished data) from our laboratory found that trypsin mediated cleavage of titin 
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molecules actually eliminated transient tension overshoots (Schuster, J.M., The 
University of Missouri Master’s Thesis, “The contribution of titin to striated muscle 
shortening”).  One way to more directly test the role of other myofibrillar PKA substrates 
on stretch activation would be to administer PKA to skinned skeletal muscle fiber 
preparations lacking MyBP-C.   
Stretch activation function is known to contribute to the regulation of oscillatory 
muscle contraction, i.e. sinusoidal muscle contractions of IFM and mammalian cardiac 
muscle. Skeletal muscle is generally thought to not be an oscillatory muscle, which may 
be why relative stretch-activated force is not as great in skeletal muscle.  However, 
spontaneous oscillatory contractions (SPOCs) have been reported in a number of studies 
examining the mechanics of permeabilized cardiac myocyte preparations and skeletal 
muscle fibers (72, 84).  Interestingly, in this study we observed that PKA treatment both 
markedly increased the number of SPOCs and yielded greatest relative transient force 
overshoots in skinned slow-twitch skeletal muscle fibers.  A similar phenomenon has 
been reported in rat skinned cardiac myocyte preparations (29).  The relationship between 
SPOCs and stretch activation and whether they share similar molecular mechanism 
requires additional studies.    
Future studies to further assess stretch activation and its potential underlying 
mechanism include perhaps starting with a comparative study of permeabilized IFM, 
cardiac muscle, and slow-twitch and fast-twitch skeletal muscle using the same 
methodology in order to quantify the amplitude and kinetics of stretch activation between 
muscle types.  Additional experiments could incorporate a high molecular weight 
polymer such as dextran to compress the myofilament lattice towards values more closely 
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associated with intact muscle (42, 72).  Dextran is thought to cause the thick filament to 
favor the OFF state (19), thus the presence of dextran is hypothesized to elicit smaller 
transient force overshoots in skinned slow-twitch skeletal muscle fibers; however, 
following PKA treatment there will be a pronounced increase in relative transient force 
overshoot.  It has been proposed that titin not only contributes to passive tension, but also 
active force generation through the extension and refolding titin domains (66).  The 
extension and refolding of the domains could contribute to stretch activation.  
Blebbistatin, a known suppressor of the thick filament (19), would provide a model for 
testing titin’s contribution to stretch activation in a Ca2+ activated muscle.  Additional 
experiments could quantify the role of thick and thin filament proteins in the marked 
increase in transient force overshoots observed in skinned cardiac myocyte preparations 
(29).  For instance, since slow-twitch skeletal TnI does not contain PKA site, cardiac TnI 
with pseudophosphorylated PKA sites could be exchanged into skinned slow-twitch 
skeletal muscle fibers.  The effects of this exchange on transient force overshoots before 
and after PKA treatment would provide a quantitative assessment of the role of each 
protein and whether the effects elicit a zero sum, additive, or synergistic gain.  Using a 
cMyBP-C ablation mouse model, stretch activation was found to be enhanced in skinned 
myocardial preparations (79).  It is hypothesized that the addition of MyBP-C molecules 
to the skinned muscle preparations lacking MyBP-C would attenuate stretch activation 
capability.  
Overall, work from this thesis found evidence for stretch activation in both 
permeabilized fast-twitch and slow-twitch skeletal muscle fibers.  Stretch activation, 
which was quantified as transient force overshoot after slack-re-stretch maneuver, has 
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been hypothesized to arise from cooperative activation of the thin filament (12).  If in 
fact, stretch activation is a result of cooperative activation of the thin filament, then we 
hypothesized that skinned fast-twitch fibers would elicit greater stretch activation due to 
its higher relative level of cooperativity.  Contrary to our hypothesis, transient force 
overshoots were greater in the less cooperative slow-twitch skeletal muscle fiber, which 
suggests that stretch activation may not be solely due to the extent of apparent 
cooperative activation of force in myofilament system.  Following slack-re-stretch 
maneuver, force redevelopment rates were quantified and found to be best fit with a 
double exponential equation.  Interestingly, at low Ca2+ activation levels (25%), the two 
phases of force redevelopment converged into one process.  The rate of relaxation of the 
transient force overshoot also was quantified (by time to half of force decay (t1/2)) and 
was considerable faster but less Ca2+ activation dependent in fast-twitch skeletal muscle 
fiber preparations.  Next, the role of PKA-mediated MyBP-C phosphorylation on stretch 
activation was assessed using slow-twitch skeletal muscle fibers.  Interestingly, the 
transient force overshoot increased by greater than two-fold following PKA treatment at 
low levels of Ca2+ activation.  In addition, force redevelopment rates were significantly 
increased across the entire range of Ca2+ activation levels.   In a similar manner, transient 
force decay rates had a tendency of being faster following PKA treatment.  Overall, these 
are consistent with a model whereby stretch transiently increases the number of cross-
bridges made available for force generation and PKA phosphorylation of MyBP-C 
enhances these stretch activation processes.  These results are consistent with a regulation 
of contraction model whereby MyBP-C has an inhibitory role on the myosin cross-
bridges, which may be relieved following phosphorylation.  Future studies are needed to 
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provide a more complete mechanistic understanding of stretch activation in mammalian 
striated muscle during normal contractions and how these regulatory processes are altered 
with acute increases in metabolic demands and by chronic changes in muscle function 
associated with exercise training and disease states.  
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